Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-004762

CVP,Strategy/Corp Development sold 6,725 shares at $83.09 ($558,801)

  • CVP,Strategy/Corp Development acquired 6,725 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BOBO DONALD E JR · CVP,Strategy/Corp Development

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-06 Exercise or conversion : show line 1 in the form 10b5-1 +6,725 $35.20 $236,698 69,548.69 D
2023-04-06 Sale : show line 2 in the form 10b5-1 −6,725 $83.09 $558,801 62,823.69 D
Open-market sales · 6,725 sh · avg $83.09 · $558,801

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-04-06 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −6,725 $35.20 2023-05-11 6,725 0 D
Loading xslF345X04/doc4.xml…